Targeted Oncology
@targetedonc
Oncology news and insights from leading researchers and cancer centers.
ID: 726304448
http://targetedonc.com 30-07-2012 15:43:54
43,43K Tweet
20,20K Takipçi
3,3K Takip Edilen
Ruxolitinib Therapy for cGVHD: Insights on Patient and Safety Monitoring | Duke Hematologic Malignancies & Cellular Therapy hubs.li/Q03j6WL80